Skip to main content

4 Result(s)

within Mark Goldammer Remove this filter

and

  1. No Access

    Article

    Therapeutische Immunisierungen gegen Tumore und neurodegenerative Erkrankungen

    Therapeutische Impfstoffe sollen die körpereigene Immunabwehr bei bereits bestehenden Erkrankungen aktivieren.

    Verena Scheer, Mark Goldammer, Sven Flindt… in Bundesgesundheitsblatt - Gesundheitsforsch… (2020)

  2. No Access

    Article

    Pharmacokinetic drug–drug interaction between ethinyl estradiol and gestodene, administered as a transdermal fertility control patch, and two CYP3A4 inhibitors and a CYP3A4 substrate

    Pharmacokinetic (PK) interactions between the cytochrome P450 3A4 (CYP3A4) pathway and transdermally administered ethinyl estradiol (EE) and gestodene (GSD) were investigated. This paper reports the findings o...

    Julia Winkler, Mark Goldammer… in European Journal of Drug Metabolism and Ph… (2015)

  3. No Access

    Article

    Vitamin D receptor haplotypes protect against development of colorectal cancer

    We investigated the association of vitamin D receptor polymorphisms and colorectal cancer incidence in a Caucasian population.

    Jana Flügge, Solveigh Krusekopf… in European Journal of Clinical Pharmacology (2007)

  4. No Access

    Article

    Effect of Genetic Polymorphisms in Cytochrome P450 (CYP) 2C9 and CYP2C8 on the Pharmacokinetics of Oral Antidiabetic Drugs

    Type 2 diabetes mellitus affects up to 8% of the adult population in Western countries. Treatment of this disease with oral antidiabetic drugs is characterised by considerable interindividual variability in ph...

    Dr Julia Kirchheiner, Ivar Roots, Mark Goldammer… in Clinical Pharmacokinetics (2005)